Sarissa Capital Management LP — 13F Holdings

2026 Q3  ·  10 Positions

2026 Q3 Portfolio Activity

In 2026 Q3, Sarissa Capital Management LP maintained a portfolio of 10 distinct positions. The fund also reduced its exposure to AMARIN CORP PLC by 23.1%.
Position History hover any row below to update
Loading…
Sarissa Capital Management LP Greenwich, CT Hedge Fund / Activist Investor AUM $153M
PCA Score Concentration Risk
Risk ENB
Total Positions
10
Quarter
2026 Q3
Top Holding
INVA (26.2%)
Top 10 Concentration
100.0%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
Showing 1-10 of 10

Sarissa Capital Management LP Full Holdings List — 2026 Q3

Stock History Sector / Type Port % Prev % Rank / Prev Conviction
Freshness
Change % Change Influence Shares Mkt Value Avg Cost Price Held 1st Owned Source Source Date Date Reported
INVA
INNOVIVA INC
Healthcare 26.18% 24.14% #1
Prev: #1
7.0
—
no change no change
P
S
1,890,604 $40,099,711
$12.89 +41.9%
$21.21 -13.7%
2016 Q3 13F Filing 2026-09-30 2026-11-16
IRWD
IRONWOOD PHARMA...
Healthcare 23.82% 21.75% #2
Prev: #2
6.5
—
no change no change
P
S
9,188,635 $36,478,881
$10.77 -54.8%
$3.97 +22.7%
2017 Q4 13F Filing 2026-09-30 2026-11-16
AMRN
AMARIN CORP PLC
Healthcare 10.92% 15.00% #3
Prev: #3
5.0
—
-386,305 -23.1%
P
S
1,287,090 $16,732,170
$50.94 -77.9%
$13.00 -13.3%
2021 Q3 13F Filing 2026-09-30 2026-11-16
LNTH
LANTHEUS HLDGS ...
Healthcare 10.85% 10.41% #4 2
Prev: #6
5.5
—
no change no change
P
S
166,919 $16,613,448 2024 Q3 13F Filing 2026-09-30 2026-11-16
NBIX
NEUROCRINE BIOS...
Healthcare 10.79% 11.04% #5 1
Prev: #4
5.5
—
no change no change
P
S
116,533 $16,529,041 2023 Q2 13F Filing 2026-09-30 2026-11-16
CYTK
CYTOKINETICS IN...
Healthcare 9.84% 10.95% #6 1
Prev: #5
4.9
—
no change no change
P
S
228,623 $15,068,542 2024 Q1 13F Filing 2026-09-30 2026-11-16
BHVN
BIOHAVEN LTD
Healthcare 5.08% 4.87% #7
Prev: #7
3.0
—
no change no change
P
S
582,312 $7,773,865 2025 Q4 13F Filing 2026-09-30 2026-11-16
REGN
REGENERON PHARM...
Healthcare 2.07% 1.47% #8
Prev: #8
1.8
—
no change no change
P
S
4,190 $3,177,151 2025 Q3 13F Filing 2026-09-30 2026-11-16
VOR
VOR BIOPHARMA I...
Healthcare 0.32% 0.26% #9
Prev: #9
1.1
—
no change no change
P
S
25,399 $484,613 2021 Q1 13F Filing 2026-09-30 2026-11-16
BIIB
BIOGEN INC
Healthcare 0.14% 0.12% #10
Prev: #10
1.1
—
no change no change
P
S
950 $214,586 2015 Q4 13F Filing 2026-09-30 2026-11-16
Showing 1-10 of 10 holdings

Unlock Full Sarissa Capital Management LP Analysis

PRO subscribers get access to all historical quarters, Excel/CSV exports, Portfolio Concentration Analytics (PCA), and Risk-Based ENB.

Full Historical Quarters
Excel & CSV Export
PCA & Risk-Based ENB
Auto Cost Basis
Position Change Alerts
Price-Held Analytics
Full history →